Clinical Trials Directory

Trials / Completed

CompletedNCT05866484

Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS)

Testicular Sperm Aspiration (TESA) vs. Microfluidic Sperm Separation (MSS) in Couples With High Sperm DNA Fragmentation Undergoing ICSI: Which Approach is Better

Status
Completed
Phase
Study type
Observational
Enrollment
280 (actual)
Sponsor
Clinique Ovo · Industry
Sex
Male
Age
18 Years
Healthy volunteers
Not accepted

Summary

Normal embryonic development relies on the correct transmission of genetic information, and sperm DNA plays a crucial part in this process. Causes of poor sperm DNA integrity include unhealthy lifestyles such as smoking and exposure to gonadotoxins, as well as, obesity, varicoceles, infections, advanced paternal age and systemic disorders. An increase in DNA fragmentation in sperm has been linked to lower fertilisation rate, poorer quality embryos, lower pregnancy rate, and high miscarriages rate. The best way for sperm selection and processing in assisted reproductive technologies (ART) should be noninvasive and cost-effective. It should also make it possible to identify high-quality spermatozoa and produce more favorable results in terms of pregnancy and live birth rates.7 Meanwhile, the microfluidic sperm separation technology is a less expensive and less invasive alternative. This method allows for the selection of motile sperm that have a normal morphology, low levels of reactive oxygen species (ROS), and low DFI

Conditions

Timeline

Start date
2023-05-10
Primary completion
2024-03-30
Completion
2024-05-31
First posted
2023-05-19
Last updated
2024-07-12

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05866484. Inclusion in this directory is not an endorsement.